Gregory D. Casciaro
Former CEO and Current Director
United States of America
Gregory D. Casciaro has been a director since December 2014. He has served as a director of QT Vascular Ltd., a medical device company, since 2001. Prior to QT Vascular, Mr. Casciaro served as the president and CEO of AccessClosure, Inc., a medical device company that was acquired by Cardinal Health, Inc. Prior to joining AccessClosure, he was the president, CEO and a director of XTENT, Inc., a medical device company that was acquired by Biosensors International Group, Ltd. Previously, Mr. Casciaro served as the president, CEO and a director of Orquest Inc., a private company manufacturing and selling bio-therapeutic products to the orthopedic market. Mr. Casciaro previously served as a director of AngioDynamics, Inc. and Kerberos Proximal Solutions. He was president, CEO and a director at General Surgical Innovations, Inc., a laparoscopic surgical equipment manufacturer that was acquired by United States Surgical, a division of Tyco Healthcare Group, and held executive and management positions at Vascular Intervention, a division of Guidant Corporation, North American Instrument Corporation, and Procter & Gamble Co. Mr. Casciaro graduated from Marquette University with a B.A. in Business Administration.